Needle-Free IV Connectors are routinely used in the hospitals for intravenous administration of fluids and medicines to protect the hubs in vascular access systems. In order to reduce risks of possible contaminations associated with the IV administration and to curb manipulation as much as possible, needle free IV connectors can prove to be ideal in all types of IV infusions. Furthermore, technological advancements such as connectors that prevent fluid reflux, highly closed systems, and connectors embedded with antimicrobial agents (V-Link) have helped to decrease the risk of bloodstream infections associated with IV administration. Needle-free connectors are with extended dwell time that can help preventing intraluminal contamination and device cross-contamination, which can be favorable for the growth of the market in the near future.

Get In-Depth Sample Copy of This Report @ https://www.coherentmarketinsights.com/insight/request-sample/426

Market Dynamics

Government organizations and regulatory bodies namely Centers for Disease Control and prevention (CDC) have recommended the usage of needle-free connectors to reduce the incidence of sharp injuries and blood stream infections mandating its usage in medical facilities in the ‘Guidelines for the Prevention of Intravascular Catheter-Related Infections’ in 2011. Major issues associated with the conventional options of intravenous infusion are contamination from external sources during administration, blood reflux, and risk of bloodstream infections, which are addressed by needle-free IV connectors. The National Healthcare Safety Network (NHSN) conducts various programs worldwide that helps to impart education and hands on training sessions to all physicians and nurses about the usage of needle-free connectors and insertion of central venous catheters in children and adults. The advantages of needle-free IV connectors over conventional IV administration namely, safer access to IV lines without using needle, reduced risk of bloodstream infections and reduced possibility of contamination, rising chronic diseases prevalence and cost containment through use of needle-free IV connectors is expected to boost the growth of needle-free IV connectors market over the forecast period.

The global needle-free IV connectors market was valued at US$ 621.1 million in 2016 and is expected to reach a robust CAGR of 10.3% over the forecast period (2017-2025).

Rising incidence and prevalence of various chronic diseases and need for treatment is expected to boost the needle-free connectors market

North America accounts for the largest share in the global needle-free connectors market, followed by Europe. This is mainly attributed to the rise in the geriatric population and chronic diseases. According to the Centers for Disease Control and Prevention (CDC), 2016, about half of American adults, that is around 117 million people had one or more chronic health conditions and one in four adults had two or more chronic health conditions. The factors driving the growth of the needle-free IV connectors market includes government investments and funding to improve healthcare infrastructure, awareness in people, and healthcare practitioners.

Competitive Landscape

Some major players operating in the needle-free IV connectors market are Baxter International Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, CareFusion Corporation, ICU Medical, Inc., Nexus Medical LLC, RyMed Technologies, LLC, and Vygon SA.

Detailed Segmentation:

Global Needle-Free IV Connectors Market, By Design Type:

Simple

Complex

Global Needle-Free IV Connectors Market, By Mechanism:

Positive

Negative

Neutral

Global Needle-Free IV Connectors Market, By Dwell Time:

Seven-Day

Other than Seven-Day

Browse Complete Report @ https://www.coherentmarketinsights.com/market-insight/needle-free-iv-connectors-market-426

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Needle-Free IV Connectors are routinely used in the hospitals for intravenous administration of fluids and medicines to protect the hubs in vascular access systems. In order to reduce risks of possible contaminations associated with the IV administration and to curb manipulation as much as possible, needle free IV connectors can prove to be ideal in all types of IV infusions. Furthermore, technological advancements such as connectors that prevent fluid reflux, highly closed systems, and connectors embedded with antimicrobial agents (V-Link) have helped to decrease the risk of bloodstream infections associated with IV administration. Needle-free connectors are with extended dwell time that can help preventing intraluminal contamination and device cross-contamination, which can be favorable for the growth of the market in the near future.

Get HOLISTIC Request Sample Copy Of This Business Report:

https://www.coherentmarketinsights.com/insight/request-sample/426

Market Dynamics

Government organizations and regulatory bodies namely Centers for Disease Control and prevention (CDC) have recommended the usage of needle-free connectors to reduce the incidence of sharp injuries and blood stream infections mandating its usage in medical facilities in the ‘Guidelines for the Prevention of Intravascular Catheter-Related Infections’ in 2011. Major issues associated with the conventional options of intravenous infusion are contamination from external sources during administration, blood reflux, and risk of bloodstream infections, which are addressed by needle-free IV connectors. The National Healthcare Safety Network (NHSN) conducts various programs worldwide that helps to impart education and hands on training sessions to all physicians and nurses about the usage of needle-free connectors and insertion of central venous catheters in children and adults. The advantages of needle-free IV connectors over conventional IV administration namely, safer access to IV lines without using needle, reduced risk of bloodstream infections and reduced possibility of contamination, rising chronic diseases prevalence and cost containment through use of needle-free IV connectors is expected to boost the growth of needle-free IV connectors market over the forecast period.

Some major players operating in the needle-free IV connectors market are Baxter International Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, CareFusion Corporation, ICU Medical, Inc., Nexus Medical LLC, RyMed Technologies, LLC, and Vygon SA.

Market Taxonomy

This report segments the global IV Connectors (Needle-free) market on the basis of design type, mechanism, and dwell time. On the basis of design type, the global needle-free IV connectors market is segmented into Simple and Complex. Mechanisms of needle-free IV connectors include positive, negative, and neutral. Needle-free IV connectors are segmented by dwell time as seven-day dwell time and other than seven-day.

Key features of the study:

• This report provides in-depth analysis of needle-free IV connectors and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2017 as the base year

• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players

• It profiles leading players in the global Needle-Free IV Connectors market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans

• Key companies covered as a part of this study include Baxter International, Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, CareFusion Corporation, ICU Medical, Inc., Nexus Medical LLC, RyMed Technologies, LLC, and Vygon SA

According to the World Health Organization (WHO), annually around 1 million deaths are associated with the improper use of syringes and needles, which can be prevented by using needle-free IV connectors. Harmful diseases namely hepatitis and HIV can spread through improper and reuse of needles and syringes. Unsafe use of injections accounts for 5% of HIV, 40% of Hepatitis C and 32% of Hepatitis B virus infections globally. Although needle stick injuries are uncommon they are a potential problem, which can prove to be serious and are also responsible for causing above mentioned diseases. According to the Centers for Disease Control and Prevention (CDC), needle stick injuries account for around 385,000 among healthcare workers in the U.S annually. The most important goal while employing IV administration sets and needle-free connectors is to reduce the manipulation factor as much as possible. Some of the U.S. Food & Drug Administration (FDA) approved needle-free IV connectors include One-Link, CARESITE, MaxPlus, and Kendall.

“The global needle-free IV connectors market was valued at US$ 621.1 million in 2016 and is expected to reach a robust CAGR of 10.3% over the forecast period (2017-2025).”

Click To Reading More On Needle-free IV Connectors Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Needle-Free IV Connectors are needleless devices for connecting administration sets, syringes, and IV catheters. Depending on internal characteristic and functioning of the parts, connectors are classified as simple and complex. Simple connectors consist of stationary internal parts, whereas, complex connectors function according to the movement of internal parts. Simple connector’s category holds the majority of the products used in the healthcare delivery. The fluid displacement and fluid pathway are determined by the motion of the internal parts namely mechanical valve, which controls the movement and direction of the fluid in complex connectors. External characteristics such as housing, shape, and color for both the type may or may not be similar. The purpose of using needle-free IV connectors apart from the ease in infusion for both care providers and patients is to reduce the risk of needle-stick injuries among the health care providers and reducing the risk of bacterial and microbial contamination.

Some major players operating in the needle-free IV connectors market are Baxter International Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, CareFusion Corporation, ICU Medical, Inc., Nexus Medical LLC, RyMed Technologies, LLC, and Vygon SA.

Request Sample Copy Of This Research Report:

https://www.coherentmarketinsights.com/insight/request-sample/426

According to the World Health Organization (WHO), annually around 1 million deaths are associated with the improper use of syringes and needles, which can be prevented by using needle-free IV connectors. Harmful diseases namely hepatitis and HIV can spread through improper and reuse of needles and syringes. Unsafe use of injections accounts for 5% of HIV, 40% of Hepatitis C and 32% of Hepatitis B virus infections globally. Although needle stick injuries are uncommon they are a potential problem, which can prove to be serious and are also responsible for causing above mentioned diseases. According to the Centers for Disease Control and Prevention (CDC), needle stick injuries account for around 385,000 among healthcare workers in the U.S annually. The most important goal while employing IV administration sets and needle-free connectors is to reduce the manipulation factor as much as possible. Some of the U.S. Food & Drug Administration (FDA) approved needle-free IV connectors include One-Link, CARESITE, MaxPlus, and Kendall.

The global needle-free IV connectors market was valued at US$ 621.1 million in 2016 and is expected to reach a robust CAGR of 10.3% over the forecast period (2017-2025).

Needle free iv connector market

Rising incidence and prevalence of various chronic diseases and need for treatment is expected to boost the needle-free connectors market

North America accounts for the largest share in the global needle-free connectors market, followed by Europe. This is mainly attributed to the rise in the geriatric population and chronic diseases. According to the Centers for Disease Control and Prevention (CDC), 2016, about half of American adults, that is around 117 million people had one or more chronic health conditions and one in four adults had two or more chronic health conditions. The factors driving the growth of the needle-free IV connectors market includes government investments and funding to improve healthcare infrastructure, awareness in people, and healthcare practitioners. For instance, in 2013, the National Healthcare Safety Network (NHSN) and Center for Disease Control and Prevention (CDC) carried out surveillance methods to identify and track device-associated infections by setting the guidelines for the prevention of central-line associated bloodstream infections. Furthermore, according to the World Health Organization (WHO), in 2014, chronic diseases were the leading cause of mortality in Europe with over one-third of the European population above the age of 15 suffering with a chronic disease and two out of three people near 60 age had at least two chronic conditions.

Download the PDF brochure:

https://www.coherentmarketinsights.com/insight/request-pdf/426

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Visit our news Website: https://www.coherentwire.com

Needle-Free IV Connectors are routinely used in the hospitals for intravenous administration of fluids and medicines to protect the hubs in vascular access systems. In order to reduce risks of possible contaminations associated with the IV administration and to curb manipulation as much as possible, needle free IV connectors can prove to be ideal in all types of IV infusions. Furthermore, technological advancements such as connectors that prevent fluid reflux, highly closed systems, and connectors embedded with antimicrobial agents (V-Link) have helped to decrease the risk of bloodstream infections associated with IV administration. Needle-free connectors are with extended dwell time that can help preventing intraluminal contamination and device cross-contamination, which can be favorable for the growth of the market in the near future.

Get HOLISTIC Request Sample Copy Of This Business Report:

https://www.coherentmarketinsights.com/insight/request-sample/426

Market Dynamics

Government organizations and regulatory bodies namely Centers for Disease Control and prevention (CDC) have recommended the usage of needle-free connectors to reduce the incidence of sharp injuries and blood stream infections mandating its usage in medical facilities in the ‘Guidelines for the Prevention of Intravascular Catheter-Related Infections’ in 2011. Major issues associated with the conventional options of intravenous infusion are contamination from external sources during administration, blood reflux, and risk of bloodstream infections, which are addressed by needle-free IV connectors. The National Healthcare Safety Network (NHSN) conducts various programs worldwide that helps to impart education and hands on training sessions to all physicians and nurses about the usage of needle-free connectors and insertion of central venous catheters in children and adults. The advantages of needle-free IV connectors over conventional IV administration namely, safer access to IV lines without using needle, reduced risk of bloodstream infections and reduced possibility of contamination, rising chronic diseases prevalence and cost containment through use of needle-free IV connectors is expected to boost the growth of needle-free IV connectors market over the forecast period.

Some major players operating in the needle-free IV connectors market are Baxter International Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, CareFusion Corporation, ICU Medical, Inc., Nexus Medical LLC, RyMed Technologies, LLC, and Vygon SA.

Market Taxonomy

This report segments the global IV Connectors (Needle-free) market on the basis of design type, mechanism, and dwell time. On the basis of design type, the global needle-free IV connectors market is segmented into Simple and Complex. Mechanisms of needle-free IV connectors include positive, negative, and neutral. Needle-free IV connectors are segmented by dwell time as seven-day dwell time and other than seven-day.

Key features of the study:

This report provides in-depth analysis of needle-free IV connectors and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2017 as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players

It profiles leading players in the global Needle-Free IV Connectors market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans

Key companies covered as a part of this study include Baxter International, Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, CareFusion Corporation, ICU Medical, Inc., Nexus Medical LLC, RyMed Technologies, LLC, and Vygon SA

According to the World Health Organization (WHO), annually around 1 million deaths are associated with the improper use of syringes and needles, which can be prevented by using needle-free IV connectors. Harmful diseases namely hepatitis and HIV can spread through improper and reuse of needles and syringes. Unsafe use of injections accounts for 5% of HIV, 40% of Hepatitis C and 32% of Hepatitis B virus infections globally. Although needle stick injuries are uncommon they are a potential problem, which can prove to be serious and are also responsible for causing above mentioned diseases. According to the Centers for Disease Control and Prevention (CDC), needle stick injuries account for around 385,000 among healthcare workers in the U.S annually. The most important goal while employing IV administration sets and needle-free connectors is to reduce the manipulation factor as much as possible. Some of the U.S. Food & Drug Administration (FDA) approved needle-free IV connectors include One-Link, CARESITE, MaxPlus, and Kendall.

“The global needle-free IV connectors market was valued at US$ 621.1 million in 2016 and is expected to reach a robust CAGR of 10.3% over the forecast period (2017-2025).”

Click To Reading More On Needle-free IV Connectors Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

Worldwide Market Reports added Latest Research Report titled “Needle-free IV Connectors Market - Industry Insights, Market Segmentation, Opportunities, Trends & Future Scope Till 2025 ”to its Large Report database.

The Global Needle-free IV Connectors Market by design (simple and complex), mechanism (positive, negative, and neutral), dwell time (seven-day and other than seven-day) and region (North America, Latin America, Europe, Asia-Pacific, the Middle East, and Africa) was valued at US$ 621.1 million in 2016 and is projected to exhibit a CAGR of 10.3% over the forecast period (2017-2025), as highlighted in a new report published by Coherent Market Insights. Growing prevalence of chronic diseases with need of treatment for the same, the risk of possible bloodstream infections and effectiveness over conventional IV administration are expected to be the major factors driving the growth of the global needle-free IV connectors market over the forecast period.
Manufacturers are focusing on minimizing the risks associated with IV administration with conventional methods as well as any existing minor issues associated with the use of needle-free IV connectors namely blood reflux caused by gasket compression and blood reflux due to disconnection. For instance, MicroClave connector from ICU Medical provides minimal blood reflux in the catheter tip. The company has received three type of the U.S. patents for MicroClave clear needle-free connector in 2015 and 2016. RyMed Technologies developed InVision-Plus with the neutral advantage technology designed to reduce the bacterial contamination. Furthermore, Nexus Medicals has designed a next generation infusion therapy technology, Nexus TKO to solve infection and occlusion issues.
Browse 70 Market Data Tables and 30 Figures spread through 200 Pages and in-depth TOC on "" Needle-Free IV Connectors Market by Design (simple and complex), Mechanism (positive, negative, and neutral), Dwell Time (seven-day and other than seven-day) and Region (North America, Latin America, Europe, Asia-Pacific, the Middle East, and Africa) - Global Forecast to 2025

Request for Sample Copy of Research Report: https://www.worldwidemarketreports.com/sample/202046

Manufacturers are working on developing and providing connectors for intravenous as well as for other routes of administration. ICU Medical's Tego needle-free connector is world's first Food and Drug Administration (FDA) approved in hemodialysis applications. Furthermore, in 2016, Vygon S.A. launched Nutrifit enteral connectors, which are used for neonates and newborns for safe and secure enteral feeding. The companies have resorted to mergers and acquisitions in the past few years to make use of the innovative IV administration technologies present in the market along with increasing their own product portfolio in order to create a strong presence in the intravenous therapies market, which is expected to propel the market growth over the forecasted period. In 2017, ICU Medical completed acquisition of Hospira Infusion Systems from Pfizer Inc., in 2014 Becton, Dickinson and Company acquired CareFusion Corporation and Medtronic Plc acquired Covidien
Get Best Discount on Research Report: https://www.worldwidemarketreports.com/discount/202046

Key Takeaways of the Needle-Free IV Connectors Market:
• The global needle-free IV connectors market is expected to exhibit a CAGR of 3% over the forecast period (2016-2025), owing to the presence of high potential markets, especially in Asia Pacific, Latin America, the Middle East, and Africa
• Robust developments in connector designs, mergers and acquisitions, and inclusion of novel connector technologies in the market are expected to drive the global needle-free IV connectors market.
• Some major players operating in the needle-free IV connectors market are Baxter International Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, CareFusion Corporation, ICU Medical, Inc., Nexus Medical LLC, RyMed Technologies, LLC, and Vygon SA.

**If you have any special requirements, please let us know and we will offer you the report as you want.

About WMR

Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.

Contact Us:

Mr. Shah

Worldwide Market Reports

1001 4th Ave,

#3200

Seattle, WA 98154,

U.S

Tel: +1 415 871 0703

Email: sales@worldwidemarketreports.com